AstraZeneca Reports Q4 and Full-Year 2022 Results with Strong Revenue Growth
UK-based multinational AstraZeneca Plc (AZ, NASDAQ: AZN) has released its financial results for the Q4...
Finanical Reports
Siemens Healthineers Reports Q1 Revenue Drop Amid COVID-19 Impact
Germany-based medical device giant Siemens Healthineers AG has released its fiscal year 2023 Q1 financial...
Astellas Pharma Reports Strong Q3 Results with 17.3% Revenue Growth
Japan-based Astellas Pharma Inc. (TYO: 4503) has released its financial report for Q3 of its...
Gilead Sciences Reports Q4 and Full-Year 2022 Financial Results
US major Gilead Sciences, Inc. (NASDAQ: GILD) last week reported Q4 and full-year 2022 financial...
Sanofi Reports Strong Q4 and Full-Year 2022 Financials with 7% Growth
France’s Sanofi (EPA: SAN) released its financial report last week, showing turnover during Q4 and...
Amgen Reports Q4 and Full-Year 2022 Financials with Global Sales Growth
US major Amgen (NASDAQ: AMGN) has released its Q4 and full-year 2022 financials. Global sales...
GSK Reports Strong Q4 and Full-Year 2022 Financials Amid Strategic Shift
UK-based GlaxoSmithKline plc (NYSE: GSK) has released its financial report for Q4 and the full-year...
Roche Reports 2% YOY Growth in 2022; Ocrevus and Hemlibra Drive Sales
Swiss pharmaceutical giant Roche (SWX: RO) released its 2022 financial report this week, recording CHF...
Merck & Co. Posts 22% YOY Sales Growth; Keytruda and Gardasil Drive Revenues
Merck & Co. (NYSE: MRK) has released its Q4 and full-year 2022 financial report, showcasing...
Takeda Posts Strong Q3 Results, Announces Pipeline Advances in Oncology and Rare Diseases
Japan-based pharmaceutical giant Takeda (TYO: 4502, NYSE: TAK) has announced its financial results for the...
GenScript’s CAR-T Therapy Carvykti Achieves $55M in Sales, Awaits China Approval
China-based Contract Research Organization (CRO) GenScript Biotech Corporation (HKG: 1548) has announced that sales of...
Innovent Biologics Posts Strong Q4 Revenues Amid COVID-19 Challenges
Innovent Biologics Inc. (HKG: 1801) announced product revenues of RMB 1 billion (USD 148.2 million)...
Eli Lilly Reports Q4 Financials with COVID-19 Impact and Market Performers
Eli Lilly & Co. (NYSE: LLY) reported its Q4 2022 financials, revealing a 9% year-on-year...
Novo Nordisk Posts Strong 2022 Results; GLP-1 Therapies Drive Growth
Denmark-based diabetes giant Novo Nordisk (NYSE: NVO) has reported financial results for the fourth quarter...
Pfizer Reports Record Revenues as COVID-19 Sales Soar; 2023 Guidance Amid Market Shifts
US-based Pfizer Inc. (NYSE: PFE) reported its Q4 2022 financial results, highlighting an all-time high...
Novartis Q4 Results Show Growth in Innovative Medicines Amid Sandoz Spin-Off Plans
Swiss pharmaceutical giant Novartis (NYSE: NVS) has released its financial results for Q4 and the...
Abbott’s Q4 Sales Dip Amid COVID-19 Testing Decline, China Market Updates
US-based Abbott (NYSE: ABT) released its Q4 2022 financial results last week, showing a 6.1%...
Burning Rock Upgrades 2022 Revenue Growth Forecast to 10% YOY
Guangzhou-based medical device giant Burning Rock Ltd (NASDAQ: BNR) has issued a notice upgrading its...
HKEX 2022 Annual Report: IPO Activity Declines Amid Global Challenges
The Hong Kong Exchanges and Clearing Ltd (HKEX) has released its annual report for 2022,...
Sinovac Reports H1 2022 Financials Amid COVID-19 Vaccine Demand Decline
China-based Sinovac Biotech Ltd (NASDAQ: SVA) has released its financial report for the first half...